Ocular Therapeutix, Inc. (OCUL) Insider Trading

Over the last 3 months, OCUL insiders made 0 open-market buys and 5 sales, a net sale of -$444K (SEC Form 4). Over the last 6 months, 212 institutions increased and 148 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
5
Net (3m)
-$444.5K
Insider trades by month Buys Sells
Oct
Nov
Feb
May
Jun
Aug
Context3-month price +14.4%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Aug 26, 2026Nayak Sanjayofficer: Chief Strategy OfficerSell1,897$10.78
Aug 26, 2026Dugel Pravindirector, officer: See RemarksSell21,649$10.77
Aug 26, 2026Kaiser Peterofficer: Chief Development OfficerSell3,035$10.77
Aug 26, 2026Heier Jeffrey S.officer: Chief Scientific OfficerSell3,296$10.78
Jun 12, 2026Robins Jason Shandofficer: Chief Financial OfficerGrant14,024$8.74
Jun 12, 2026Graves Adrienne LdirectorGrant44,000$8.74
Jun 12, 2026Warden Charles MdirectorGrant14,000
Jun 12, 2026Williams Leslie J.directorGrant44,000$8.74
Jun 12, 2026Hong Seung SuhdirectorGrant14,000
Jun 12, 2026Robins Jason Shandofficer: Chief Financial OfficerGrant15,441
Jun 12, 2026LINDSTROM RICHARD L MDdirectorGrant44,000$8.74
Jun 12, 2026Williams Leslie J.directorGrant14,000
Jun 12, 2026Hong Seung SuhdirectorGrant44,000$8.74
Jun 12, 2026Graves Adrienne LdirectorGrant14,000
Jun 12, 2026RAINES MERILEEdirectorGrant14,000
Jun 12, 2026Warden Charles MdirectorGrant44,000$8.74
Jun 12, 2026RAINES MERILEEdirectorGrant44,000$8.74
Jun 12, 2026LINDSTROM RICHARD L MDdirectorGrant14,000
Jun 5, 2026Waheed Nadiaofficer: Chief Medical OfficerSell14,828$8.27
May 28, 2026Heier Jeffrey S.officer: Chief Scientific OfficerSell3,018$8.20
May 28, 2026Dugel Pravindirector, officer: See RemarksSell21,156$8.20
May 28, 2026Kaiser Peterofficer: Chief Development OfficerSell2,967$8.20
May 28, 2026Nayak Sanjayofficer: Chief Strategy OfficerSell1,858$8.20
Feb 25, 2026Kaiser Peterofficer: Chief Development OfficerSell2,810$8.28
Feb 25, 2026Dugel Pravindirector, officer: See RemarksSell20,056$8.28
Feb 25, 2026Nayak Sanjayofficer: Chief Strategy OfficerSell1,759$8.28
Feb 25, 2026Heier Jeffrey S.officer: Chief Scientific OfficerSell3,057$8.28
Feb 24, 2026Waheed Nadiaofficer: Chief Medical OfficerSell3,510$7.74
Feb 24, 2026LINDSTROM RICHARD L MDdirectorBuy60,229$7.66
Feb 17, 2026Dugel Pravindirector, officer: See RemarksSell124,882$9.04

Source: OCUL SEC Form 4 filings, latest Aug 26, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their OCUL positions over the last 6 months (SEC Form 13F).

Increased
212
New positions
111
Reduced
148
Sold out
40
Largest moves
InstitutionActionSharesFiled
FMR LLCIncreased32.8MAug 13, 2026
FMR LLCIncreased32.7MMay 15, 2026
DEEP TRACK CAPITAL, LPIncreased19.7MMay 15, 2026
Deep Track Capital, LPUnchanged19.7MAug 14, 2026
BlackRock, Inc.Increased19.4MAug 7, 2026
BLACKROCK, INC.Increased16.1MMay 13, 2026
Avoro Capital Advisors LLCIncreased12.5MAug 14, 2026
AVORO CAPITAL ADVISORS LLCReduced12.3MMay 15, 2026
SUMMER ROAD LLCIncreased12.2MAug 10, 2026
SUMMER ROAD LLCIncreased11.9MApr 23, 2026
AVORO CAPITAL ADVISORS LLCIncreased10.8MMar 16, 2026
VR Adviser, LLCUnchanged10.3MAug 14, 2026
VR ADVISER, LLCIncreased10.3MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased8.8MAug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position8.7MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.